[1] Chen CR, Nadeau S, Yared M, Voinov P, Xie N, Roemer C, et al. CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants. Bioinformatics 2022;38(6):1735 − 7. https://doi.org/10.1093/bioinformatics/btab856CrossRef
[2] Ma KC, Shirk P, Lambrou AS, Hassell N, Zheng XY, Payne AB, et al. Genomic surveillance for SARS-CoV-2 variants: circulation of omicron lineages - United States, January 2022-May 2023. MMWR Morb Mortal Wkly Rep 2023;72(24):651 − 6. https://doi.org/10.15585/mmwr.mm7224a2CrossRef
[3] UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 52. 2023. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1152143/variant-technical-briefing-52-21-april-2023.pdf. [2023-8-27].
[4] Hodcroft E. CoVariants: SARS-CoV-2 variants and mutations that are of interest. 2021. https://covariants.org/. [2023-8-27].
[5] Wang SW, Niu PH, Su QD, He XZ, Tang J, Wang J, et al. Genomic surveillance for SARS-CoV-2 - China, September 26, 2022 to January 29, 2023. China CDC Wkly 2023;5(7):143 − 51. https://doi.org/10.46234/ccdcw2023.026CrossRef
[6] World Health Organization. TAG-VE statement on omicron sublineages BQ.1 and XBB. 2022. https://www.who.int/news/item/27-10-2022-tag-ve-statement-on-omicron-sublineages-bq.1-and-xbb. [2023-8-27].
[7] Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun 2023;14(1):2800. https://doi.org/10.1038/s41467-023-38435-3CrossRef
[8] Sharma T, Gerstman B, Chapagain P. Distinctive features of the XBB. 1.5 and XBB.1.16 spike protein receptor-binding domains and their roles in conformational changes and angiotensin-converting enzyme 2 binding. Int J Mol Sci 2023;24(16):12586. https://doi.org/10.3390/ijms241612586CrossRef
[9] Qu PK, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ. 1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 2023;31(1):9 − 17.e3. https://doi.org/10.1016/j.chom.2022.11.012CrossRef
[10] Bhattacharya M, Chatterjee S, Lee SS, Dhama K, Chakraborty C. Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants. Drug Resist Updat 2023;71:101008. https://doi.org/10.1016/j.drup.2023.101008CrossRef
[11] Yue C, Song WL, Wang L, Jian FC, Chen XS, Gao F, et al. ACE2 binding and antibody evasion in enhanced transmissibility of XBB. 1.5. Lancet Infect Dis 2023;23(3):278 − 80. https://doi.org/10.1016/S1473-3099(23)00010-5CrossRef
[12] Yamasoba D, Uriu K, Plianchaisuk A, Kosugi Y, Pan L, Zahradnik J, et al. Virological characteristics of the SARS-CoV-2 omicron XBB. 1.16 variant. Lancet Infect Dis 2023;23(6):655 − 6. https://doi.org/10.1016/S1473-3099(23)00278-5CrossRef
[13] Fang LT, Xu J, Zhao Y, Fan JY, Shen JY, Liu WB, et al. The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2. Front Microbiol 2023;14:1228128. https://doi.org/10.3389/fmicb.2023.1228128CrossRef
[14] Feng YN, Zhao X, Yin ZY, Wu CC, Chen ZX, Nie K, et al. Surveillance and analysis of SARS-CoV-2 variant importation - China, January-June 2022. China CDC Wkly 2022;4(50):1136 − 42. https://doi.org/10.46234/ccdcw2022.229CrossRef
[15] Zhou L, Nie K, Zhao HT, Zhao X, Ye BX, Wang J, et al. Eleven COVID-19 outbreaks with local transmissions caused by the imported SARS-CoV-2 delta VOC - China, July-August, 2021. China CDC Wkly 2021;3(41):863 − 8. https://doi.org/10.46234/ccdcw2021.213CrossRef